The New Executive and Appendix Template (NEAT) Study
The NEAT Study: An Examination of a Novel Consent Form Design in a Real-world Setting
2 other identifiers
interventional
101
1 country
1
Brief Summary
There is evidence that the current design and content provided by most biomedical research informed consent documents do not consistently meet the expectations researchers place on them to effectively inform research participants of information thought to be most important in facilitating their ability to make informed decisions about participation. The need for revisions to the informed consent document design is supported by empirical research.This pilot study will examine the effectiveness of the New Executive and Appendix Template (NEAT) form when used in the consent process for individuals participating in the Atherosclerosis Risk in Communities (ARIC) Neurocognitive Study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 23, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 23, 2017
CompletedFirst Submitted
Initial submission to the registry
January 22, 2018
CompletedFirst Posted
Study publicly available on registry
February 5, 2018
CompletedResults Posted
Study results publicly available
October 13, 2023
CompletedOctober 13, 2023
September 1, 2023
2 months
January 22, 2018
September 20, 2023
September 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comprehension of the NEAT Form
Following the consent process, participants will be administered the Comprehension tool to measure their comprehension. The summary scores will be used to address the primary aim of whether or not the NEAT consent form improves participant comprehension. There are 7 questions, each question is rated 0-2 with a total scale of 0-14. Higher values denotes better outcomes.
at visit one, up to 24 hours
Secondary Outcomes (4)
Qualitative Analysis of the Readability and Understandability of the Consent Form by Participants
at visit one, up to 24 hours
Qualitative Analysis of the Format and Design of the Consent Form by Participants
at visit one, up to 24 hours
Qualitative Analysis of the Time of Discussion of the Consent Form by Participants
at visit one, up to 24 hours
Qualitative Analysis of the Format and Design of the Consent Form by Study Team
at visit one, up to 24 hours
Study Arms (2)
NEAT Form
EXPERIMENTALStudy participants will be randomized to the NEAT form and the materials that accompany it (also detailing the ARIC study).
Standard Form
ACTIVE COMPARATORStudy participants will be randomized to the traditional standard consent form (detailing the ARIC study).
Interventions
The NEAT form consists of a clear and concise overview document containing information satisfying all elements of consent. This is made up of IRB-approved wording from the regular consent form. More detailed information, such as specific clinic measures are provided as additional material and are discussed during the consent process after the general overview has been provided with the NEAT form.
Eligibility Criteria
You may qualify if:
- Individuals who are eligible for the ARIC study, with which this pilot study is cooperating.
You may not qualify if:
- Any individuals not eligible for the ARIC study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, 27157, United States
Results Point of Contact
- Title
- Joseph E. Andrews, Jr., PhD, CIP, CCRP
- Organization
- Wake Forest School of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph Andrews, PhD
Wake Forest University Health Sciences
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2018
First Posted
February 5, 2018
Study Start
April 4, 2017
Primary Completion
May 23, 2017
Study Completion
May 23, 2017
Last Updated
October 13, 2023
Results First Posted
October 13, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share